Scoop has an Ethical Paywall
Scoop InfoPages
This InfoPage in unregistered, if this is your news page register PHARMAC for InfoPages here.
PHARMAC - Latest News [Page 20]
PHARMAC achieves excellent result in 2006
Friday, 10 November 2006, 4:53 pm | PHARMAC
A huge jump in the number of people receiving subsidised medicines and a record number of prescriptions are recorded in PHARMAC’s 2006 Annual Report. More >>
HIV treatment takes two steps forward
Wednesday, 1 November 2006, 11:13 am | PHARMAC
A once-a-day medicine to attack the HIV/AIDS virus is part of a package of treatments for people with HIV announced by Pharmac today. Atazanavir (Reyataz) is a once a day HIV protease inhibitor which has the advantage of having fewer metabolic side ... More >>
Herceptin status unchanged
Monday, 16 October 2006, 11:59 am | PHARMAC
Herceptin is to remain unfunded for early stage breast cancer for the present time, PHARMAC said today. More >>
PHARMAC To Fund Prader-Willi Growth Hormone
Tuesday, 3 October 2006, 3:00 pm | PHARMAC
A growth hormone that enhances the lives of children with Prader-Willi syndrome is now fully funded. More >>
Brand change for ADHD medication
Friday, 29 September 2006, 3:57 pm | PHARMAC
New Zealanders taking long-acting methylphenidate – mostly children with the behavioural condition Attention Deficit Hyperactivity Disorder (ADHD) – will see a change in the brand of their medication from 1 November. More >>
PHARMAC to fund medicine for acute heart patients
Thursday, 28 September 2006, 3:08 pm | PHARMAC
From 1 October 2006, people with acute heart problems will benefit from a decision by PHARMAC to subsidise clopidogrel, a drug that helps prevent blood clots developing in arteries. More >>
Breast cancer treatments get a funding boost
Thursday, 31 August 2006, 3:43 pm | PHARMAC
Treatments for early breast cancer are getting a boost with a decision to fund the taxane drug paclitaxel for early breast cancer. More >>
New weapon for battle against HIV/AIDS
Thursday, 24 August 2006, 4:06 pm | PHARMAC
The first of a new type of drugs to treat HIV/AIDS will be funded for New Zealanders from next month. More >>
Further Herceptin information received by PTAC
Thursday, 17 August 2006, 4:39 pm | PHARMAC
PHARMAC’s clinical advisory committee PTAC today considered further information on the use of Herceptin for early breast cancer. More >>
PHARMAC: Herceptin - Questions and answers
Friday, 28 July 2006, 3:50 pm | PHARMAC
Why is Herceptin not yet funded in NZ? The evidence on Herceptin is not yet strong enough to enable PHARMAC to make a positive funding decision on Herceptin. PHARMAC remains open to funding the drug and will be continuously reviewing further evidence ... More >>
Herceptin not funded, under continuing review
Friday, 28 July 2006, 1:41 pm | PHARMAC
Funding has not yet been approved for breast cancer drug Herceptin, but will be kept under review by Government drug-funding agency PHARMAC as new information emerges. More >>
Asthma inhaler range gets a positive shake-up
Wednesday, 26 July 2006, 11:09 am | PHARMAC
Subsidies for asthma inhalers will get a big shake-up from 1 August. More people will be able to have long-acting inhalers, such as Oxis and Serevent, because of relaxed prescribing rules which see Special Authorities removed. More >>
Obesity epidemic fuels worrying diabetes trends
Tuesday, 4 July 2006, 9:29 am | PHARMAC
The obesity epidemic is behind a disturbing rise in diabetes in New Zealand, with this age-related disease now increasingly hitting teenagers. More >>
Antibiotics secured for influenza pandemic
Monday, 26 June 2006, 2:52 pm | PHARMAC
New Zealanders will have access to a secure supply of antibiotics for use during an influenza pandemic. More >>
Once-a-day insulin subsidised for NZ patients
Monday, 26 June 2006, 9:43 am | PHARMAC
A type of insulin for people with diabetes that requires only one injection a day will be funded from 1 July, PHARMAC announced today. More >>
10 days to 17 seconds at the touch of a button
Wednesday, 21 June 2006, 9:53 am | PHARMAC
Medicines approvals that had taken 10 days can now occur in as little as 17 seconds, thanks to a new electronic system available for doctors. More >>
Herceptin given full consideration by PTAC
Thursday, 25 May 2006, 3:41 pm | PHARMAC
The Pharmacology and Therapeutics Advisory Committee today considered further clinical evidence on the use of trastuzumab (Herceptin) for early breast cancer. More >>
More choice for heart risk patients
Thursday, 11 May 2006, 2:25 pm | PHARMAC
Chief Executive Wayne McNee says the listing of Cartia provides further choice for patients wanting to reduce their chance of having a heart attack or stroke. Cartia is the second brand of low dose aspirin to be subsidised following the decision to ... More >>
Funding moves take on hepatitis B
Thursday, 6 April 2006, 11:58 am | PHARMAC
New moves to tackle the leading cause of liver cancer have been announced by drug-funding agency PHARMAC. More >>
PHARMAC agrees funding for brain tumour treatment
Monday, 3 April 2006, 3:24 pm | PHARMAC
A new treatment for people with an aggressive form of brain tumour is to become fully subsidised from 1 May 2006. More >>
